147 related articles for article (PubMed ID: 29330546)
21. Descriptive epidemiology of Down's syndrome in Estonia.
Reimand T; Ounap K; Zordania R; Ilus T; Uibo O; Sitska M; Talvik T
Paediatr Perinat Epidemiol; 2006 Nov; 20(6):512-9. PubMed ID: 17052289
[TBL] [Abstract][Full Text] [Related]
22. The Natural History of Trisomy 21: Outcome Data from a Large Tertiary Referral Centre.
O'Connor C; Moore R; McParland P; Hughes H; Cathcart B; Higgins S; Mahony R; Carroll S; Walsh J; McAuliffe F
Fetal Diagn Ther; 2021; 48(8):575-581. PubMed ID: 34583352
[TBL] [Abstract][Full Text] [Related]
23. Trends in live birth prevalence of down syndrome in the Northern Netherlands 1987-96: the impact of screening and prenatal diagnosis.
Wortelboer MJ; De Wolf BT; Verschuuren-Bemelmans CC; Reefhuis J; Mantingh A; Beekhuis JR; Cornel MC
Prenat Diagn; 2000 Sep; 20(9):709-13. PubMed ID: 11015698
[TBL] [Abstract][Full Text] [Related]
24. [Prenatal diagnosis and prevalence of Down syndrome in the Parisian population, 2001-2005].
de Vigan C; Khoshnood B; Cadio E; Vodovar V; Goffinet F
Gynecol Obstet Fertil; 2008 Feb; 36(2):146-150. PubMed ID: 18249576
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of prenatal follow-up strategies for trisomy 21 affected pregnancies in France].
Dupont JM; Simon-Bouy B; Zebina A; Pessione F; Royère D; Doco-Fenzy M;
Gynecol Obstet Fertil Senol; 2017 Mar; 45(3):152-157. PubMed ID: 28258854
[TBL] [Abstract][Full Text] [Related]
26. A population-based study of prevalence of Down syndrome in Southern Thailand.
Jaruratanasirikul S; Kor-Anantakul O; Chowvichian M; Limpitikul W; Dissaneevate P; Intharasangkanawin N; Sattapanyo A; Pathompanitrat S; Sriplung H
World J Pediatr; 2017 Feb; 13(1):63-69. PubMed ID: 27878784
[TBL] [Abstract][Full Text] [Related]
27. Impact of prenatal diagnosis on revised livebirth prevalence estimates of Down syndrome in the Lothian region of Scotland, 1978-1992.
Huether CA; Haroldson K; Ellis PM; Ramsay CN
Genet Epidemiol; 1996; 13(4):367-75. PubMed ID: 8894639
[TBL] [Abstract][Full Text] [Related]
28. [Impact of maternal age distribution on the expected live birth prevalence of Down's syndrome in the metropolitan France between 1965 and 2008].
Rousseau T; Ferdynus C; Thauvin-Robinet C; Gouyon JB; Sagot P
J Gynecol Obstet Biol Reprod (Paris); 2010 Jun; 39(4):284-9. PubMed ID: 20381272
[TBL] [Abstract][Full Text] [Related]
29. European non-invasive trisomy evaluation (EU-NITE) study: a multicenter prospective cohort study for non-invasive fetal trisomy 21 testing.
Verweij EJ; Jacobsson B; van Scheltema PA; de Boer MA; Hoffer MJ; Hollemon D; Westgren M; Song K; Oepkes D
Prenat Diagn; 2013 Oct; 33(10):996-1001. PubMed ID: 23794121
[TBL] [Abstract][Full Text] [Related]
30. Association between timing of diagnosis of trisomy 21, 18, and 13 and maternal socio-economic status in Victoria, Australia: A population-based cohort study from 2015 to 2016.
Kluckow E; Halliday J; Poulton A; Lindquist A; Hutchinson B; Bethune M; Bonacquisto L; Da Silva Costa F; Gugasyan L; Harraway J; Howden A; Kulkarni A; Martin N; McCoy R; Menezes M; Nisbet D; Palma-Dias R; Pertile MD; Poulakis Z; Hui L
Prenat Diagn; 2019 Dec; 39(13):1254-1261. PubMed ID: 31691307
[TBL] [Abstract][Full Text] [Related]
31. Prenatal diagnosis versus first-trimester screening of trisomy 21 among pregnant women aged 35 or more.
Ghi T; Arcangeli T; Ravennati F; Salsi G; Montaguti E; Pacella G; Maroni E; Pittalis MC; Pompilii E; Pilu G; Rizzo N
J Matern Fetal Neonatal Med; 2015 Apr; 28(6):674-8. PubMed ID: 24866349
[TBL] [Abstract][Full Text] [Related]
32. Impact of prenatal screening and diagnostic testing on trends in Down syndrome births and terminations in Western Australia 1980 to 2013.
Maxwell S; Bower C; O'Leary P
Prenat Diagn; 2015 Dec; 35(13):1324-30. PubMed ID: 26411476
[TBL] [Abstract][Full Text] [Related]
33. Prenatal diagnosis of trisomy 21: registration results from a single genetic center.
Witters I; Fryns JP
Genet Couns; 2008; 19(2):157-63. PubMed ID: 18618989
[TBL] [Abstract][Full Text] [Related]
34. Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis.
Neyt M; Hulstaert F; Gyselaers W
BMJ Open; 2014 Nov; 4(11):e005922. PubMed ID: 25380810
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of Down syndrome in Glasgow, 1980-96--the growing impact of prenatal diagnosis on younger mothers.
Iliyasu Z; Gilmour WH; Stone DH
Health Bull (Edinb); 2002 Jan; 60(1):20-6. PubMed ID: 12664764
[TBL] [Abstract][Full Text] [Related]
36. Non-invasive prenatal screening for trisomy 21: what women want and are willing to pay.
Verweij EJ; Oepkes D; de Vries M; van den Akker ME; van den Akker ES; de Boer MA
Patient Educ Couns; 2013 Dec; 93(3):641-5. PubMed ID: 24011429
[TBL] [Abstract][Full Text] [Related]
37. Recent trends in the prevalence of Down syndrome in Japan, 1980-1997.
Hoshi N; Hattori R; Hanatani K; Okuyama K; Yamada H; Kishida T; Yamada T; Sagawa T; Sumiyoshi Y; Fujimoto S
Am J Med Genet; 1999 Jun; 84(4):340-5. PubMed ID: 10340648
[TBL] [Abstract][Full Text] [Related]
38. A new approach of digital PCR system for non-invasive prenatal screening of trisomy 21.
Lee SY; Kim SJ; Han SH; Park JS; Choi HJ; Ahn JJ; Oh MJ; Shim SH; Cha DH; Hwang SY
Clin Chim Acta; 2018 Jan; 476():75-80. PubMed ID: 29170101
[TBL] [Abstract][Full Text] [Related]
39. Maternal Age-Specific Rates for Trisomy 21 and Common Autosomal Trisomies in Fetuses from a Single Diagnostic Center in Thailand.
Jaruthamsophon K; Sriplung H; Charalsawadi C; Limprasert P
PLoS One; 2016; 11(11):e0165859. PubMed ID: 27812158
[TBL] [Abstract][Full Text] [Related]
40. [Are there any changes in Down Syndrome prevalence in France following the implementation of the measurement of nuchal translucency and maternal serum screening?].
Goujard J
Gynecol Obstet Fertil; 2004 Jun; 32(6):496-501. PubMed ID: 15217564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
